XLY News 67.47 07/23/2014 05:57:06 Consumer Discret Select Sector

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Consumer Discret Select Sector SPDR (XLY) 67.47 $XLY

'Fast Money' Recap: Confusion in the Market
at The Street - Fri Jul 11, 4:00AM CDT
The trading panel discussed whether investors are too complacent and whether it's a good idea to buy Microsoft again.

Could Earnings Prove Consumer Goods Pessimists Wrong?
Joseph Hogue, The Motley Fool - Motley Fool - Thu Jul 10, 6:00PM CDT
The consumer discretionary group is the only sector that posted a loss for the first half of the year, as it trailed the S&P 500 by more than 6%. Poor consumer spending in the first quarter drove earnings expectations lower and analysts largely...

Utilities, Energy, Health Care Are the ETFs to Beat This Year
at The Street - Thu Jul 03, 10:10AM CDT
I track 11 exchange-traded funds, and the best year-to-date performer is utilities, while health care set an all-time high on Wednesday.

'Fast Money' Recap: Let Your Winning Trades Keep Running
at The Street - Wed Jul 02, 4:00AM CDT
The trading panel discussed yet another closing high for the S&P 500 and DJIA plus what they are buying and selling.

This U.S. Stock Market Is Not Dealing in Reality as It Moves Higher
at The Street - Mon Jun 30, 4:32PM CDT
The stock market on Monday closed out the second quarter in mixed fashion. The DJIA is oversold while the Nasdaq is overbought.

A Stock Market Selloff With Some Volume and Power Behind It
at The Street - Tue Jun 24, 4:20PM CDT
The stock indexes closed down on Tuesday after an intraday turn from the upside. The downside volume was big in comparison to the upside volume for the past month.

The Zacks Analyst Blog HighlightsowerShares Dynamic Building & Construction, Consumer Discretionary Select Sector SPDR Fund, Industrials/Producer Durables AlphaDEX Fund and SPDR S&P 500 ETF
PR Newswire - Tue Jun 24, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the PowerShares Dynamic Building & Construction (AMEXKB-Free Report), Consumer Discretionary Select Sector SPDR Fund (AMEX:XLY-Free Report), Industrials/Producer Durables AlphaDEX Fund (AMEX:FXR-Free Report) and SPDR S&P 500 ETF (AMEX:SPY-Free Report).

3 Cyclical ETFs to Buy in a Rebounding U.S. Economy - ETF News And Commentary
Zacks Equity Research - ZACKS - Mon Jun 23, 11:00AM CDT
These sector ETFs could benefit from a rebounding American economy.

The Surprising Sector Behind the S&P 500's Double-Digit Dividend Surge
Sean Williams, The Motley Fool - Motley Fool - Sun Jun 22, 7:15AM CDT
If you're an income-seeking investor, then you have to be pleased with the level of corporate givebacks we're witnessing from S&P 500 companies. Aggregate dividend payments for the first quarter, according to FactSet Research's Dividend...

Market Bears Make It Two in a Row Despite Increased Volume
at The Street - Thu Jun 12, 4:22PM CDT
Could this be the start of something bigger or just short-term profit-taking by the bulls?

Powerhouse ETFs: Transports and Technology Are the Best Performers
at The Street - Thu Jun 12, 10:58AM CDT
I continue to track 11 Exchange Traded Funds as a conservative way to invest in specific sectors of the stock market in an environment where stock-picking remains difficult.

How a Rising Economy Could Boost These 2 ETFs
Michael Bodman, The Motley Fool - Motley Fool - Tue May 13, 3:20PM CDT
Since the Great Recession ended in June 2009, the U.S. economy has expanded for almost five years, and the job market has improved. As the economy expands, cyclical stocks stand to gain.  Cyclicality refers to the sensitivity of a stock's price...

Powerhouse ETFs: Energy, Consumer Staples and Utilities Outperform
at The Street - Mon May 12, 12:03PM CDT
There are 11 Exchange Traded Funds that provide a conservative way to invest in specific sectors without the risk of stock picking.

Utilities, Health Care Leading ETF Sectors
at The Street - Wed Apr 02, 9:15AM CDT
Here are some investments to get exposure to broad sectors in the economy.

Cracks Beneath the Market's Surface
at The Street - Tue Mar 25, 10:45AM CDT
Even though the market has hit new highs, weakness lurks below. What should you do as an investor?

An ETF Strategy for a Volatile Second Quarter
at The Street - Mon Mar 24, 10:28AM CDT
Selecting the right exchange-traded funds will help the investor play defense in this environment.

Time to Bet on Consumer Discretionary ETFs? - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Tue Mar 18, 9:00AM CDT
Is now the time to buy these consumer ETFs?

Amazon Prime Fee Hike--Good for the Stock? - Real Time Insight
Neena Mishra - Zacks Investment Research - Thu Mar 13, 1:53PM CDT
Will the price increase drive away customers or result in increased spending?
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 356

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 371

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 150

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 347

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 204

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 309

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 238

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 177

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 433

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 243

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading

Top 5 Most Recently Viewed Articles

Air Canada Navigates Operational Challenges Amid Storms

Updated Category News Views 205

Air Canada's Operational Challenges and Responses Air Canada has recently faced significant operational hurdles due to severe winter weather and an aircraft incident impacting its Toronto Pearson international hub. These challenges have necessitated a comprehensive update from the airline about its current status and ongoing recovery efforts. Recent Weather Impact on...

Continue Reading
Insight into Melexis' Ongoing Share Buy-Back Strategy

Updated Category News Views 128

Melexis Enhances Shareholder Value Through a Strategic Buyback Melexis, a leader in the semiconductor industry, has been actively engaging in a strategic share buy-back program aimed at bolstering shareholder value. This initiative, first announced on December 10, 2024, reflects the company's commitment to enhancing its stock's performance while also optimizing its...

Continue Reading
Value Line, Inc. Launches New Share Repurchase Initiative

Updated Category News Views 220

Value Line, Inc. Announces Stock Repurchase Program Value Line, Inc. (NASDAQ: VALU) recently revealed an exciting development for its shareholders: the Board of Directors has approved a share repurchase program that allows for the buyback of up to $2,000,000 worth of shares. This program comes into effect immediately and marks a significant move that replaces the previous...

Continue Reading
IsoEnergy Expands Stake in Premier American Uranium Inc. Assets

Updated Category News Views 154

IsoEnergy Enhances Investment in Premier American Uranium Inc. IsoEnergy Ltd. (NYSE American: ISOU) (TSX: ISO) has recently expanded its investment in Premier American Uranium Inc. by acquiring a significant number of common shares and warrants. This strategic move further establishes IsoEnergy’s commitment to capitalizing on the promising uranium market amid increasing...

Continue Reading
Texas Attorney General Takes Action Against Insulin Price Fixing

Updated Category News Views 70

Texas Attorney General's Lawsuit Against Insulin Price Fixing Texas Attorney General Ken Paxton has taken significant action by filing a lawsuit against several prominent insulin manufacturers and pharmacy benefit managers (PBMs). The lawsuit highlights allegations of a conspiracy to inflate insulin prices, affecting countless patients who rely on this vital medication....

Continue Reading